World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
35951
World Ranking
7705
National Ranking
755

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His primary areas of investigation include Cancer, Internal medicine, Incidence, Epidemiology and Surgery. His studies deal with areas such as Absolute risk reduction and Cohort as well as Cancer. His Internal medicine study frequently draws connections to adjacent fields such as Oncology.

The various areas that Henrik Møller examines in his Incidence study include Cervix, Relative risk, Gynecology, Disease and Testicular cancer. His work deals with themes such as Helicobacter pylori infection, Adenocarcinoma, Cohort study and Risk factor, which intersect with Epidemiology. His Surgery research is multidisciplinary, relying on both Comorbidity, Lymphoma and Confidence interval.

His most cited work include:

  • An international association between Helicobacter pylori infection and gastric cancer (989 citations)
  • EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary (878 citations)
  • Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. (488 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Cancer, Internal medicine, Incidence, Oncology and Cancer registry. His Cancer research incorporates elements of Lung cancer, Surgery, Cohort study and Pediatrics. His Surgery study combines topics in areas such as Odds ratio, Disease and Confidence interval.

His Incidence research is multidisciplinary, incorporating elements of Epidemiology, Gerontology, Cervix, Gynecology and Socioeconomic status. His Gynecology research includes elements of Risk factor, Etiology, Testicular cancer and Obstetrics. Henrik Møller combines subjects such as Colorectal cancer and Survival analysis with his study of Cancer registry.

He most often published in these fields:

  • Cancer (48.90%)
  • Internal medicine (46.92%)
  • Incidence (25.77%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (46.92%)
  • Cancer (48.90%)
  • Oncology (26.43%)

In recent papers he was focusing on the following fields of study:

Henrik Møller mostly deals with Internal medicine, Cancer, Oncology, Testicular microlithiasis and Prostate cancer. The Breast cancer research Henrik Møller does as part of his general Cancer study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. As part of the same scientific family, Henrik Møller usually focuses on Oncology, concentrating on Pathology and intersecting with Liquid biopsy.

His research integrates issues of Socioeconomic status, Gynecology, Testicular cancer and Urology in his study of Testicular microlithiasis. His work investigates the relationship between Prostate cancer and topics such as Prostate that intersect with problems in Stage, Ovarian cancer, Rectum and Cervix. Epidemiology and Incidence are the subject areas of his Cancer registry study.

Between 2015 and 2021, his most popular works were:

  • Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL (115 citations)
  • Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. (78 citations)
  • Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome. (77 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

Henrik Møller mainly focuses on Internal medicine, Cancer, Oncology, Prostate cancer and Cohort study. His Internal medicine study typically links adjacent topics like Endocrinology. His Cancer research is multidisciplinary, incorporating perspectives in Lung cancer, Chemotherapy and Pediatrics.

His study in Oncology is interdisciplinary in nature, drawing from both PET-CT and Progression-free survival. His Cohort study study integrates concerns from other disciplines, such as Odds ratio, Disease, Cohort and Emergency medicine. His Epidemiology study combines topics from a wide range of disciplines, such as Young adult and Surgery.

Best Publications

  • An international association between Helicobacter pylori infection and gastric cancer

    D Forman;M Coleman;Gui De Backer;J Eider

  • EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

    M Sant;T Aareleid;F Berrino;M Bielska Lasota

  • Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

    Jack Cuzick;Gregory P Swanson;Gabrielle Fisher;Arthur R Brothman

  • Cancer in the European Community and its member states.

    O. Møller Jensen;J. Estève;H. Møller;H. Renard

  • EPIDEMIOLOGY OF, AND RISK-FACTORS FOR, HELICOBACTER-PYLORI INFECTION AMONG 3194 ASYMPTOMATIC SUBJECTS IN 17 POPULATIONS.

    D Forman;Gui De Backer;J Elder;H Moller

  • Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

    G Attard;J Clark;L Ambroisine;G Fisher

  • Obesity and cancer risk: a danish record-linkage study

    Henrik Møller;Anders Mellemgaard;Knud Lindvig;Jørgen H. Olsen

  • Projections of cancer prevalence in the United Kingdom, 2010-2040.

    Jacob Maddams;M. Utley;Henrik Møller

  • Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

    Freddie Bray;Anja H. Loos;Peter McCarron;Elizabete Weiderpass

  • Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

    Freddie Bray;Bendix Carstensen;Henrik Møller;Marco Zappa

  • Rheumatoid arthritis and cancer risk.

    L. Mellemkjær;M.S. Linet;G. Gridley;M. Frisch

  • Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

    J. Cuzick;D. M. Berney;G. Fisher;D. Mesher

  • Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection

    Thomas Powles;David Robinson;Justin Stebbing;Jonathan Shamash

  • Risk of testicular cancer in men with abnormal semen characteristics: cohort study.

    Rune Jacobsen;Erik Bostofte;Gerda Engholm;Johnni Hansen

  • Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    John N Newton;John N Newton;Adam D M Briggs;Christopher J L Murray;Daniel Dicker

  • Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality

    Freddie Ian Bray;Lorenzo Richiardi;Anders Ekbom;Eero Pukkala

  • Cryptorchidism and hypospadias in sons of gardeners and farmers.

    Ida Sloth Weidner;Henrik Moller;Tina Kold Jensen;Niels E. Skakkebaek

  • Decline in sex ratio at birth after Kobe earthquake.

    Misao Fukuda;Kyomi Fukuda;Takashi Shimizu;Henrik Møller

  • Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study

    Farhad Islami;Akram Pourshams;Dariush Nasrollahzadeh;Dariush Nasrollahzadeh;Farin Kamangar

  • Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

    Manuela Marron;Manuela Marron;Paolo Boffetta;Zuo Feng Zhang;David Zaridze

Frequent Co-Authors

Jack Cuzick
Jack Cuzick Queen Mary University of London
Daniel M. Berney
Daniel M. Berney Barts Health NHS Trust
Peter T. Scardino
Peter T. Scardino Memorial Sloan Kettering Cancer Center
Lars Holmberg
Lars Holmberg King's College London
Christopher S. Foster
Christopher S. Foster University of Liverpool
Freddie Bray
Freddie Bray International Agency For Research On Cancer
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Colin Cooper
Colin Cooper University of East Anglia
Michael W. Kattan
Michael W. Kattan Cleveland Clinic
James A. Eastham
James A. Eastham Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, there are several related online degrees and alternative pathways you can explore. For example, some students interested in healthcare look into online direct entry msn programs. These are ideal for non-nurses aiming to fast-track their way into advanced nursing roles, often requiring no previous nursing experience.

Getting started doesn’t have to be daunting—even if academic requirements are a concern. Many aspiring nurses research what is the easiest nursing school to get into to find accessible programs tailored to a variety of educational backgrounds.

Healthcare careers go beyond direct patient care. Those interested in administrative roles might consider medical billing and coding schools with financial aid. These programs are often flexible, affordable, and allow students to work in healthcare settings without hands-on patient contact.

Additionally, some nursing schools no longer require standardized tests. If you’re curious, you can learn more about programs that do not mandate entrance exams like the TEAS, by reading do you have to take a teas test for lpn.

Best Scientists Citing Henrik Møller

Trending Scientists

Recently Published Articles